Professor Steve Ward has urged the antimalarial drug community to develop joint action plans to help funding agencies make the best use of available resources to tackle malaria in the future. Writing with Ian Boulton in SciDev.Net, Steve highlights the importance of coordination in antimalarial drug design and the success that the CRIMALDDI consortium has already had in identifying priority research areas.